Results for

Expanded Genetic Screening Act of 2020 This bill requires state Medicaid programs to cover noninvasive prenatal genetic screening for pregnant women. (Noninvasive prenatal genetic screening uses naturally occurring fetal DNA from the mother's blood to screen for genetic abnormalities.)

Genetic Information Privacy Act of 2019 This bill prohibits commercial genetic testing services from disclosing consumers' personally identifiable information to third parties without the consumer's express consent. In the case of the disclosure of personally identifiable information for medical research, a genetic testing service must follow the federal rules for obtaining informed consent in the context of research involving human subjects. Further, genetic testing services must provide consumers with the option to consent to disclose a consumer's genetic information but not to disclose other personally identifiable information. A genetic testing service may not condition services on obtaining consent to disclose such information. The Federal Trade Commission (FTC) must promulgate regulations establishing how genetic testing services are required to secure such personally identifiable information against unauthorized access. The bill grants the FTC and state attorneys general powers to enforce compliance with the requirements of this bill.

Access to Genetic Counselor Services Act of2019 This bill provides for coverage under Medicare of genetic counseling services that are furnished by genetic counselors. Covered services include those services, as well as incidental services and supplies, that would otherwise be covered under Medicare if provided by a physician.

Genetically Engineered Salmon Labeling Act This bill requires the market name of genetically engineered (commonly calledgenetically modifiedorGMO) salmon to includeGenetically EngineeredorGEin front of the existing market name.

Genetically Engineered Salmon Labeling Act This bill requires the market name of genetically engineered (commonly calledgenetically modifiedorGMO) salmon to includeGenetically EngineeredorGEin front of the existing market name. The Department of Health and Human Services must ensure that an independent scientific organization conducts a review of the environmental assessment carried out by the Food and Drug Administration in support of a new drug related to AquAdvantage Salmon.

This bill prohibits the sale of food that contains genetically engineered fish unless the food bears a label stating that it contains genetically engineered fish.

Prevention of Escapement of Genetically Altered Salmon in the United States Act This bill prohibits a person from * shipping, transporting, offering for sale, selling, or purchasing a genetically altered finfish (e.g., salmon), or a food product containing those fish, in commerce; * having custody, control, or possession of those fish or food products with the intent to ship, transport, offer for sale, sell, or purchase them in commerce; * engaging in net-pen aquaculture (pens of fish contained by nets) of those fish; * releasing those fish into a natural environment; or * having custody, control, or possession of those fish with the intent to release them into a natural environment. Fish, fish parts, or products confined for scientific research or collected to enforce this bill are exempted from the prohibition. An additional exemption is established if the National Oceanic and Atmospheric Administration (1) prepares a finding of no significant impact in accordance with the National Environmental Policy Act of 1969 after reviewing an application requesting a federal agency to permit activity prohibited by this bill, or (2) finds the application to be consistent with an environmental impact statement that includes an environmental risk analysis and specified assessments of costs and potential economic damage.

Equal Right to Life Act This bill prohibits prenatal genetic testing and abortions based on possible sexual orientation. Specifically, the bill establishes new criminal offenses and related penalties for a physician who (1) performs a prenatal genetic test to identify the likely sexual orientation of the child, or (2) performs an abortion as a result of a prenatal genetic test for sexual orientation. A woman who undergoes a prohibited abortion may not be prosecuted for violating or conspiring to violate the provisions of this bill.

Advancing Access to Precision Medicine Act This bill allows state Medicaid programs to cover DNA sequencing clinical services for certain individuals. Specifically, states may cover such services for individuals under the age of 21 (or a lower age, if the state chooses) and for former foster youth under the age of 26 who (1) have been referred or admitted to a pediatric intensive care unit and seen by a medical specialist for a chronic or undiagnosed disease, and (2) are suspected by a medical specialist to have a pediatric-onset genetic disease. The Centers for Medicare & Medicaid Services may award grants to assist states in developing plans to cover such services. Additionally, the National Academy of Medicine must study the effects of genetic and genomic testing and ways to expand health insurance coverage of such services, including under Medicare and Medicaid.

Ending the Diagnostic Odyssey Act of 2019 This bill allows state Medicaid programs to cover whole genome sequencing services for certain individuals. Specifically, states may cover such services for individuals under the age of 21 (or a lower age, if the state chooses) and for former foster youth under the age of 26 who (1) have been referred or admitted to an intensive care unit or seen by a medical specialist for a suspected genetic or undiagnosed disease, or (2) are suspected by a medical specialist to have a neonatal- or pediatric-onset genetic disease. The Centers for Medicare & Medicaid Services may award grants to assist states in developing plans to cover such services.

Ending the Diagnostic Odyssey Act of 2019 This bill allows state Medicaid programs to cover whole genome sequencing services for certain individuals. Specifically, states may cover such services for individuals under the age of 21 (or a lower age, if the state chooses) and for former foster youth under the age of 26 who (1) have been referred or admitted to an intensive care unit or seen by a medical specialist for a suspected genetic or undiagnosed disease, or (2) are suspected by a medical specialist to have a neonatal- or pediatric-onset genetic disease. The Centers for Medicare & Medicaid Services may award grants to assist states in developing plans to cover such services.